Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMDP) Research & Development (2019 - 2025)

Historic Research & Development for LifeMD (LFMDP) over the last 7 years, with Q3 2025 value amounting to $2.8 million.

  • LifeMD's Research & Development rose 898.23% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year increase of 1732.84%. This contributed to the annual value of $9.5 million for FY2024, which is 5695.55% up from last year.
  • Per LifeMD's latest filing, its Research & Development stood at $2.8 million for Q3 2025, which was up 898.23% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, LifeMD's Research & Development registered a high of $2.8 million during Q3 2025, and its lowest value of $122603.0 during Q2 2021.
  • For the 5-year period, LifeMD's Research & Development averaged around $1.5 million, with its median value being $1.4 million (2023).
  • In the last 5 years, LifeMD's Research & Development soared by 827.07% in 2021 and then surged by 54123.18% in 2022.
  • Quarter analysis of 5 years shows LifeMD's Research & Development stood at $216979.0 in 2021, then soared by 369.71% to $1.0 million in 2022, then skyrocketed by 96.04% to $2.0 million in 2023, then rose by 20.65% to $2.4 million in 2024, then rose by 18.08% to $2.8 million in 2025.
  • Its last three reported values are $2.8 million in Q3 2025, $2.7 million for Q2 2025, and $2.7 million during Q1 2025.